06:47 AM EST, 02/26/2025 (MT Newswires) -- United Therapeutics ( UTHR ) reported Q4 net income Wednesday of $6.19 per diluted share, up from $4.36 a year earlier.

Analysts polled by FactSet expected $6.35.

Revenue for the quarter ended Dec. 31 was $735.9 million, down from $614.7 million a year earlier.

Analysts surveyed by FactSet expected $734.7 million.

Shares of the company were up more than 2% in recent Wednesday premarket activity.

Price: 365.90, Change: +8.40, Percent Change: +2.35